Trials / Completed
CompletedNCT02384538
A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis
A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-981 to Placebo in Subjects With Erosive Hand Osteoarthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 35 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study to compare the safety and efficacy of ABT-981 to placebo in subjects with erosive hand osteoarthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ABT-981 | ABT-981 administered by subcutaneous injection |
| BIOLOGICAL | Placebo for ABT-981 | Placebo for ABT-981 administered by subcutaneous injection |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2015-03-10
- Last updated
- 2017-08-11
- Results posted
- 2017-07-13
Source: ClinicalTrials.gov record NCT02384538. Inclusion in this directory is not an endorsement.